British Pharmaceutical Conference and Exhibition 2008


SUNDAY - MONDAY - TUESDAY

am Monday 8 SEPTEMBER
10.30 – 11.00 COFFEE, EXHIBITION, BPC-PJ CAREERS FORUM PRESENTATIONS AND POSTERS

	Monday Science Posters - Further Information	Practice Posters - Further Information

THE SCIENCE OF PHARMACY	SCIENCE INTO PRACTICE	THE PRACTICE OF PHARMACY
	9.30 - 10.30 BPC 2008 Chairs’ addresses
	In the chair: Steve Churton, President, Royal Pharmaceutical Society of Great Britain
	Untold stories: control, context and culture in care homes for older people Carmel Hughes, BPC 2008 Practice Chair	12.45 - 13.30 Improving evidence for the safe and effective use of medicines in children
12.45 - 13.30 Academy of Pharmaceutical Sciences annual lecture	Adding years to life and life to years: interfacing pharmaceutical, biomedical and material sciences Andrew Lloyd, BPC 2008 Science Chair	In the chair: Peter Noyce, University of Manchester James McElnay, Queen’s University, Belfast
In the chair: President, Royal Pharmaceutical Society of Great Britain		13.40 - 15.40 A choice of:
	11.00 - 11.30 Keynote address	Show me the evidence: what can the Cochrane Collaboration do for pharmacy
The changing face of the pharma industry – past, present and future Annette Doherty, Pfizer	In the chair: Steve Churton, President, Royal Pharmaceutical Society of Great Britain	In the chair: Carmel Hughes, BPC 2008 Practice Chair
	Adding years to life and life to years Will the White Paper, Pharmacy in England: Building on strengths – delivering the future, help?	The Cochrane Collaboration and systemic review: better knowledge to better healthcare Mike Clarke, UK Cochrane Centre
13.40 - 15.40 A choice of:
Comparability of medicines (part 1)	David Colin-Thomé, Department of Health
In association with the Joint Pharmaceutical Analysis Group		The Cochrane library: an essential resource in the workplace Phil Wiffen, UK Cochrane Centre
In the chair: Ray Munden, Consultant
Demonstration of therapeutic equivalence for generic (hybrid) inhalation medicines in Europe Anders Fuglsang, Norwegian Medicines Agency, Norway	11.30 - 12.00 President’s address	OTC cough products in children: efficacy, safety and drug regulation policy Tom Fahey, Royal College of Surgeons, Ireland
	In the chair: Martin Astbury, Vice-President, Royal Pharmaceutical Society of Great Britain Steve Churton, President, Royal Pharmaceutical Society of Great Britain
Herbal medical product: how can we establish therapeutic equivalence? Michael Heinrich, School of Pharmacy, University of London		Whose evidence-base is it anyway? Informing the dialogue about risk in day-to-day health and care decision making Bob Sang, London Southbank University

Patchy responses to transdermal delivery Adrian Williams, University of Reading		Or
		How prescribers think: how to tell a dolphin from a cow
Oral drug delivery: effective design and in vivo validation of modified release systems Peter Scholes, Pharmprofiles	13.40 - 15.40 Understanding routes of infection in hospitals	In association with the National Prescribing Centre (NPC)
		In the chair: Marjorie Weiss, University of Bath
Or	In the chair: Stephen Denyer, University of Cardiff	This session will reflect on current prescribing trends within the UK with a particular focus on influences on prescribing decisions and the potential impact of non medical prescribing

Advances in controlled release and drug delivery technology (part 1)	Antimicrobial use: two sides of the same coin Jonathan Cooke, South Manchester University Hospitals NHS Trust
In association with the UKI Controlled Release Society		Neal Maskrey, Evidence Based Therapeutics, National Prescribing Centre
Sponsored by		Steve Morris, Strategic Development and Operations, National Prescribing Centre
In the chair: Yvonne Perrie, University of Aston and Simon Banks, AstraZeneca	Prevention of medical device and implant-associated infection Sean Gorman, Queen’s University, Belfast
		Or
Triggered drug delivery from biomaterials: mobilising the charge and light brigades Colin McCoy, Queen’s University, Belfast	The transmission of infection on hospital wards Clive Beggs, University of Bradford	Pharmacy 2020: a look into the future of pharmacy
		In the Chair: Beth Taylor, Chair, English Pharmacy Board
Safety and efficacy of microneedles for painless intraepidermal delivery of DNA and vaccines James Birchall, University of Cardiff	Combatting hospital associated infection in the NHS Brian Duerden, Department of Microbiology and Infection Control, Department of Health	An overview of Pharmacy 2020 David Pruce, Royal Pharmaceutical Society of Great Britain
		Community pharmacy and links to primary care Rob Daracott, Company Chemists' Assocaition
Delivery of siRNA: challenges and opportunities Catriona O’Driscoll, University College, Cork, Eire
		Prescribing and related developments Clive Jackson, National Prescribing Centre
Solid dispersion technology Abina Crean, University College, Cork, Eire
		The vision for secondary care Ray Fitzpatrick, Royal Wolverhampton Hospitals NHS Trust
Or

Neuropharmacology: future therapeutic targets for neurodegenerative diseases		Or
In association with the British Pharmacological Society		Caring for people with long-term conditions Selected papers in pharmacy practice research
In the chair: Paul Gard, University of Brighton

Animal models of cognition and putative novel therapies for neurodegenerative diseases/cognitive decline Paul Gard, University of Brighton

Current clinical burden and management of neurodegeneration/cognitive decline Greg Scutt, University of Brighton

Using psychological models of cognition to assess neurodegeneration in the elderly Jenny Rusted, University of Sussex

A pharmaceutical industry perspective – progress in the development of medicines for the treatment or prevention of neurodegenerative diseases Eric Karran, Lilly

Or

Pharmaceutical and biomedical materials (part 1)
In association with the UK Society for Biomaterials, Institute of Materials and Royal Society of Chemistry Biomaterials Group
In the chair: Cameron Alexander, and Colin Scotchford, University of Nottingham

pH-responsive DES-polyacetals for the treatment of hormone-dependent cancers María Jesús Vicent, Principe Felipe Centre of Investigation, Spain

The development and use of degradable composites in endodontic surgery Jonathan Knowles, University College London

Design and implementation of a composite scaffold for tissue engineering: the EU project VascuPlug David Grant, University of Nottingham

Materials and drug delivery, a clinician's perspective: opportunities and controversies Sheila Fisher, University of Leeds

12.00 – 13.00 LUNCH, EXHIBITION, BPC-PJ CAREERS FORUM PRESENTATIONS AND POSTERS
	Monday Science Posters - Further Information	Practice Posters - Further Information
pm Monday 8 SEPTEMBER
15.10 – 16.00 TEA, EXHIBITION, BPC-PJ CAREERS FORUM PRESENTATIONS AND POSTERS

THE SCIENCE OF PHARMACY	SCIENCE INTO PRACTICE	THE PRACTICE OF PHARMACY

16.00 - 18.00 A choice of:	16.00 - 18.00 Scientific developments in dementia and practice delivery developments	16.00 - 18.00 A choice of:
Comparability of medicines (part 2)	In the chair: Ngaire Kerse, University of Auckland, New Zealand	Pharmacy and long-term conditions: how the four nations are approaching change
In association with APS Biologics Focus Group, Joint Pharmaceutical Analysis Group and Bioprocesses UK		In the chair: Nanette Kerr, Boots UK Ltd
In the chair: Kevin King, Pfizer and Barry Moore, Xstalbio	Building a national dementia research network Steve Iliffe, University College, London	Sponsored by
		Chairmen of: Beth Taylor, English Pharmacy Board Sandra Melville, Scottish Pharmacy Board Marc Donovan, Welsh Pharmacy Board and Raymond Anderson, Pharmaceutical Society of Northern Ireland
Comparability challenges: a regulator’s perspective Janice Cook, Medical and Healthcare products Regulatory Agency	Pharmacological treatment of dementia Clive Ballard, Alzheimer’s Society
	Current practice in Alzheimer's disease Alistair Burns, University of Manchester

Assessing comparability of a biopharm product following a site manufacturing change at preclinical development stage Mike Molloy, GlaxoSmithKline	Is there an ACE in the hand for Alzheimer's disease Patrick Kehoe, University of Bristol - title to be advised	Or
		~~The Medicines Journey~~
Comparability of vaccine products: same disease, different vaccines Mike Corbel, National Institute for Biological Standards and Control		This session is being withdrawn. Hospital pharmacy issues will be covered on this day in the White Paper session and in the Pharmacy 2020 session.
Analytical comparability Graham McPherson, Avecia


Or		Or

Advances in controlled release and drug delivery technology (part 2)		Should fat be a pharmacy issue: are weight loss programmes effective in community pharmacy
In association with UKI Controlled Release Society		In association with PharmacyHealthLink In the chair: Mala Rao, Department of Health
In the chair: Karl Malcolm, Queen’s University, Belfast and Abina Crean, University College Cork, Eire		In the Chair: Richard Parish, Royal Society of Public Health
		Speakers against the motion Geof Rayner, WHO consultant Dr Colin Waine, National Obesity Forum
JDT Award Lecture – Liposome research in drug delivery: the early days Gregory Gregoriadis, Lipoxen		Speakers for the motion Fiona Harris, PharmacyHealthLink Trustee Graham Phillips, Community pharmacist, Hertford
		Followed by a reception sponsored by
Drug delivery inspired by spiky sponges Chris van der Walle, University of Strathclyde		Followed by a reception sponsored by
		Or
Controlled release of hydrophobic and hydrophilic antiviral agents from polyurethane intravaginal rings Patrick Kiser, University of Utah, USA		*The White Paper Pharmacy in England: Building on strengths – delivering the future, and its implications for pharmacists*
		In the chair: Jonathan Buisson, Boots UK Ltd
Current challenges in advancing oral controlled release Shaun Fitzpatrick, Merck
		Responsible pharmacists and skill mix Jeannette Howe, Department of Health
Or
		Public health Gul Root, Department of Health
Tackling antimicrobial resistance: recent advances in pharmaceutical microbiology
In association with Society for Applied Microbiology (SfAM)		Hospital pharmacy David Webb, Department of Health
In the chair: Brendan Gilmour and Colin McCoy, Queen’s University, Belfast		Overview Keith Ridge, Chief Pharmacist, England

Antibiotic treatment of chronic infections: time for a new paradigm? Howard Ceri, University of Calgary		Or

Modification of the bacterial phenotype: a strategy to preserve our antibacterial arsenal Peter Taylor, University of London		Protecting patients: reducing risk across the medicines spectrum Selected papers in pharmacy practice research

The challenge of multiresistant bacteria Peter Lambert, Aston University

Invited Abstract Investigation into the potential of sub-lethal photodynamic antimicrobial chemotherapy (PACT) to increase resistance to antibiotics C. Cassidy, Queen's University Belfast
Or

Regenerative medicine: the role of pharmaceutical agents
In the chair: Lucy Di Silvio, King’s College London

Orthopaedic bone cements: drug device combination Sanjukta Deb, King’s College London

Local and systemic enhancement of bone formation Elefterios Tsiridis, University of Leeds

Biodegradeable thermo-responsive hydrogels for drug delivery and tissue engineering Etienne Schacht, University of Ghent, Belgium

Bone morphogenetic proteins as therapeutic agents for tissue regeneration Vehid Salih, The Eastman Dental School

18.00 – 18.45 POSTER SESSION, SCIENCE AND PRACTICE WINE RECEPTION, POSTER PRIZES, SCIENCE AND PRACTICE POSTERS ATTENDED 20.00 ACADEMY OF PHARMACEUTICAL SCIENCES DINNER
	Monday Science Posters - Further Information	Practice Posters - Further Information

Top of page ↑

SUNDAY - MONDAY - TUESDAY

home - theme - call for papers - programme highlights - full programme - booking - press releases - awards - careers forum - social events